Regulatory functions of Nm23-H2 in tumorigenesis: Insights from biochemical to clinical perspectives

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 2, 2015, Pages 243-256

  Li, Yuanjun ^a   Tong, Yao ^a   Wong, Yung H ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cancer; Nm23 H2; Protein interaction; Tumorigenesis

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE NM23; NUCLEOSIDE DIPHOSPHATE KINASE NM23 H2; TELOMERASE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; ENZYME ACTIVITY; GENETIC LINKAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STEM CELL; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; METABOLISM; MULTIPOTENT STEM CELL; NEOPLASM; ONCOGENE MYC; PHYSIOLOGY; PROTEIN CONFORMATION;

ANIMALS; CELL DIFFERENTIATION; GENES, MYC; HUMANS; MULTIPOTENT STEM CELLS; NEOPLASMS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEIN CONFORMATION; TELOMERASE;

EID: 84926100383     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-014-1066-1     Document Type: Review

References (119)

1. Aktary Z, Chapman K, Lam L et al (2010) Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene 29:2118-2129
2. Anzinger J, Malmquist NA, Gould J, Buxton IL (2001) Secretion of a nucleoside diphosphate kinase (Nm23-H2) by cells from human breast, colon, pancreas and lung tumors. Proc West Pharmacol Soc 44:61-63
3. Arnaud-Dabernat S, Bourbon PM, Dierich A, Le Meur M, Daniel JY (2003) Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene. J Bioenerg Biomembr 35:19-30
4. Baba H, Urano T, Okada K et al (1995) Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 55:1977-1981
5. Bai F, Feng J, Cheng Y, Shi J, Yang R, Cui H (2006) Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. Int J GynecolCancer 16:202-209
6. Bal A, Joshi K, Logasundaram R, Radotra BD, Singh R (2008) Expression of nm23 in the spectrum of pre-invasive, invasive and metastatic breast lesions. Diagn Pathol 3:23
7. Berberich SJ, Postel EH (1995) PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene 10:2343-2347
8. Boissan M, Dabernat S, Peuchant E, Schlattner U, Lascu I, Lacombe ML (2009) The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem 329:51-62
9. Caligo MA, Cipollini G, Petrinit M, Valentini P, Bevilacqua G (1996) Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3. Leuk Res 20: 161-167
10. Chang CL, Zhu XX, Thoraval DH et al (1994) Nm23-H1 mutation in neuroblastoma. Nature 370:335-336
11. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC (2001) Prognostic valueof nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol 31:327-332
12. Chen S, Su L, Qiu J et al (2013) Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription. Biochim Biophys Acta 1830:4769-4777
13. Chen Y, Gallois-Montbrun S, Schneider B et al (2003) Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases. J Mol Biol 332:915-926
14. Cubukcu E, Kanat O, Fatih Olmez O et al (2013) Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer. J BUON 18:359-365
15. Dexheimer TS, Carey SS, Song ZH et al (2009) While NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression, it does not cleave the NHE III1 element. Mol Cancer Ther 8:14
16. Donate LE, Blasco MA (2011) Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci 366:76-84
17. D'Souza RJ, Sheikh ZA, Busund LT, Russell PJ, Crowe PJ, Yang JL (2003) Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade. Anticancer Res 23:3289-3294
18. Egistelli L, Chichiarelli S, Gaucci E et al (2009) IFI16 and NM23 bind to a common DNA fragment both in the P53 and the cMYC gene promoters. J Cell Biochem 106:666-672
19. Engel M, Theisinger B, Seib T et al (1993) High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer 55:375-379
20. Fernandez PC, Frank SR, Wang L et al (2003) Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129
21. Fournier HN, Dupe-Manet S, Bouvard D et al (2002) Integrin cytoplasmic domain-associated protein 1α (ICAP-α) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 277:20895-20902
22. Fournier HN, Dupe-Manet S, Bouvard D et al (2005) Nuclear translocation of integrin cytoplasmic domain-associated protein 1 stimulates cellular proliferation. Mol Biol Cell 16:1859-1871
23. Francois-Moutal L, Marcillat O, Granjon T (2014) Structural comparison of highly similar nucleoside-diphosphate kinases: molecular explanation of distinct membrane-binding behavior. Biochimie 105:110-118
24. Freije JM, Blay P, MacDonald NJ, Manrow RE, Steeg PS (1997) Site-directed mutation of Nm23-H1 mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 272:5525-5532
25. Fukuda M, Ishii A, Yasutomo Y et al (1996) Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells. Int J Cancer 65:531-537
26. Garcia I, Mayol G, Rios J et al (2012) A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res 18:2012-2023
27. Gervasi F, D'Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D (1996) Nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor. Cell Growth Differ 7:1689-1695
28. Gilles AM, Presecan E, Vonica A, Lascu I (1991) Nucleoside diphosphate kinase from human erythrocytes structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 266:8784-8789
29. Gordon GJ, Rockwell GN, Jensen RV et al (2005) Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 166:1827-1840
30. Goueli BS, Janknecht R (2004) Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol 24:25-35
31. Hailat N, Keim DR, Melhem RF et al (1991) High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345
32. Haitel A, Wiener HG, Baethge U, Marberger M, Susani M (2000) Mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters. Clin Cancer Res 6:1840-1844
33. Hamby CV, Abbi R, Prasad N et al (2000) Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Int J Cancer 88:547-553
34. Haring J, Schuler S, Lattrich C, Ortmann O, Treeck O (2012) Role of estrogen receptor beta in gynecological cancer. Gynecol Oncol 127:673-676
35. Hartsough MT, Morrison DK, Salemo M et al (2002) Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 277:32389-32399
36. Herak Bosnar M, Bago R, Konjevoda P, Pavelic J (2008) Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray. Neoplasma 55:447-454
37. Hikita ST, Kosik KS, Clegg DO, Bamdad C (2008) MUC1∗ mediates the growth of human pluripotent stem cells. PLoS One 3:e3312
38. Hippe HJ, Wolf NM, Abu-Taha HI et al (2011) Nucleoside diphosphate kinase B is required for the formation of heterotrimeric G protein containing caveolae. Naunyn Schmiedebergs Arch Pharmacol 384:461-472
39. Hudelist G, Czerwenka K, Singer C, Pischinger K, Kubista E, Manavi M (2005) cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study. Cancer Genet Cytogenet 158:35-42
40. Huwer H, Kalweit G, Engel M, Welter C, Dooley S, Gams E (1997) Expression of the candidate tumor suppressor gene nm23 in the bronchial system of patients with squamous cell lung cancer. Eur J Cardiothorac Surg 11:206-209
41. Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M (2003) Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res 23:43-47
42. Iizuka N, Tsunedomi R, Tamesa T et al (2006) Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. J Cancer Res Clin Oncol 132:473-481
43. Iwashita S, Fujii M, Mukai H, Ono Y, Miyamoto M (2004) Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem Biophys Res Commun 320:1063-1068
44. Joosten M, Blazquez-Domingo M, Lindeboom F et al (2004) Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signaling. J Biol Chem 279:38169-38176
45. Kang Y, Lee DC, Han J et al (2007) NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Biochem Biophys Res Commun 359:76-82
46. Kar A, Saha D, Purohit G et al (2012) Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells. Nucleic Acids Res 40:2554-2565
47. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32:247-258
48. Lee MJ, Xu DY, Li H et al (2012) Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Exp Mol Med 44:214-224
49. Lee MY, Jeong WJ, Oh JW, Choi KY (2009) NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway. Cancer Lett 275:221-226
50. Lim JQ, Lu J, He BP (2012) Diva/BclB regulates differentiation by inhibiting NDPKB/Nm23H2-mediated neuronal differentiation in PC-12 cells. BMC Neurosci 13:123
51. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H, Steeg PS (1993) A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268:25780-25789
52. Mahanta S, Fessler SP, Park J, Bamdad C (2008) A minimal fragment of MUC1 mediates growth of cancer cells. PLoS One 3:e2054
53. Maida Y, Kyo S, Kanaya T et al (2002) Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21:4071-4079
54. Manavi M, Hudelist G, Fink-Retter A, Gschwandtler-Kaulich D, Pischinger K, Czerwenka K (2007) Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol Oncol 105:418-426
55. Mandai M, Konishi I, Komatsu T et al (1995)Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression. Br J Cancer 72:691-695
56. Marone M, Scambia G, Ferrandina G et al (1996) Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Br J Cancer 74:1063-1068
57. Martinez JA, Prevot S, Nordlinger B et al (1995) Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37:712-720
58. Masoudi N, Fancsalszky L, Pourkarimi E et al (2013) The NM23-H1/H2 homolog NDK-1 is required for full activation of Ras signaling in C. elegans. Development 140:3486-3495
59. Mileo AM, Piombino E, Severino A, Tritarelli A, Paggi MG, Lombardi D (2006) Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J Bioenerg Biomembr 38:215-225
60. Miyamoto M, Iwashita S, Yamaguchi S, Ono Y (2009) Role of nm23 in the regulation of cell shape and migration via Rho family GTPase signals. Mol Cell Biochem 329:175-179
61. Miyazaki H, Fukuda M, Ishijima Y et al (1999) Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 5:4301-4307
62. Monig SP, Nolden B, Lubke T et al (2007) Clinical significance of nm23 gene expression in gastric cancer. Anticancer Res 27:3029-3033
63. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53:1719-1723
64. Neidle S (2010) Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J 277:1118-1125
65. New DC, Wong YH (2007) Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal 2:2. doi:10.1186/1750-2187-2-2
66. Niitsu N, Okabe-Kado J, Nakayama M et al (2000) Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood 96:1080-1086
67. Niitsu N, Okabe-Kado J, Okamoto M et al (2001) Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 97:1202-1210
68. Nosaka K, Kawahara M, Masuda M, Satomi Y, Nishino H (1998) Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun 243:342-348
69. + T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 306:G873-G885
70. Okabe-Kado J, Kasukabe T, Honma Y, Hayashi M, Henzel WJ, Hozumi M (1992) Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun 182:987-994
71. Okabe-Kado J, Kasukabe T, Baba H, Urano T, Shiku H, Honma Y (1995a) Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells. Biochim Biophys Acta 1267:101-106
72. Okabe-Kado J, Kasukabe T, Hozumi M et al (1995b) A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require its kinase activity. FEBS Lett 363:311-315
73. Okabe-Kado J, Kasukabe T, Honma Y (1998) Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia. Leuk Lymphoma 32:19-28
74. Okabe-Kado J, Kasukabe T, Honma Y (2002) Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages. Leuk Res 26:569-576
75. Okabe-Kado J, Kasukabe T (2003) Physiological and pathological relevance of extracellular NM23/NDP kinases. J Bioenerg Biomembr 35:89-93
76. Paravicini G, Steinmayr M, Andre E, Becker-Andre M (1996) The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily. Biochem Biophys Res Commun 227:82-87
77. Polanski R, Maguire M, Nield PC et al (2011)MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility. Carcinogenesis 32:1133-1142
78. Postel EH, Berberich SJ, Flint SJ, Ferrone CA (1993) Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478-480
79. Postel EH, Weiss VH, Beneken J, Kirtane A (1996) Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element. Proc Natl Acad Sci U S A 93:6892-6897
80. Postel EH, Abramczyk BM, Levit MN, Kyin S (2000) Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function. Proc Natl Acad Sci U S A 97:14194-14199
81. Postel EH, Abramczyk BA, Gursky SK, Xu Y (2002) Structure-based mutational and functional analysis identify human NM23-H2 as a multifunctional enzyme. Biochemistry 41:6330-6337
82. Postel EH, Zou X, Notterman DA, La Perle KMD (2009) Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development. Mol Cell Biochem 329:45-50
83. Radovic S, Doric M, Hukic A, Babic M, Kuskunovic S, Spahovic N (2013) Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma. Bosn J Basic Med Sci 13:72-77
84. Rayner K, Chen YX, Hibbert B et al (2007) NM23-H2, an estrogen receptor β-associated protein, shows diminished expression with progression of atherosclerosis. Am J Physiol Regul Integr Comp Physiol 292:R743-R750
85. Rayner K, Chen YX, Hibbert B et al (2008) Discovery of NM23-H2 as an estrogen receptor beta-associated protein: role in estrogen-induced gene transcription and cell migration. J Steroid Biochem Mol Biol 108:72-81
86. Rochdi MD, Laroche G, Dupre E et al (2004) Nm23-H2 interacts with a G protein-coupled receptor to regulate its endocytosis through an Rac1-dependent mechanism. J Biol Chem 279:18981-18989
87. Rumjahn SM, Javed MA, Wong N, Law WE, Buxton IL (2007) Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer 97:1372-1380
88. Sarris M, Lee CS (2001) nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Eur J Surg Oncol 27:170-174
89. Sato Y, Tsuchiya B, Urao T, Baba H, Shiku H, Kodama T, Kameya T (2000) Semiquantitative immunoblot analysis of nm23-H1 and -H2 isoforms in adenocarcinomas of the lung: prognostic significance. Pathol Int 50:200-205
90. Shaul YD, Seger R (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773:1213-1226
91. Smagghe BJ, Stewart AK, Carter MG et al (2013) MUC1∗ ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naive state. PLoS One 8:e58601
92. Srivastava S, Li Z, Ko K et al (2006) Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol Cell 24:665-675
93. Steeg PS (1991) Genetic control of the metastatic phenotype. Semin Cancer Biol 2:105-110
94. Steeg PS, Bevilacqua G, Kopper L et al (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200-204
95. Steeg PS, de la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A (1993) Nm23 and breast cancer metastasis. Breast Cancer Res Treat 25:175-187
96. Steeg PS, Zollo M, Wieland T (2011) A critical evaluation of biochemical activities reported for the nucleoside diphosphate kinase/Nm23/Awd family proteins: opportunities and missteps in understanding their biological functions. Naunyn Schmiedebergs Arch Pharmacol 384:331-339
97. Syed V, Mukherjee K, Lyons-Weiler J et al (2005) Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24:1774-1787
98. Tagashira H, Hamazaki K, Tanaka N, Gao C, Namba M (1998) Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform. Int J Mol Med 2:65-68
99. Tannapfel A, Anhalt K, Hausermann P et al (2003) Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201:238-249
100. Tas F, Tuzlali S, Aydiner A et al (2002) Prognostic role of nm23 gene expression in patients with ovarian cancer. Am J Clin Oncol 25:164-167
101. Toksoz D, Williams DA (1994) Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products. Oncogene 9:621-628
102. Tschiedel S, Gentilini C, Lange T et al (2008) Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia. Leukemia 22:1542-1550
103. Tschiedel S, Bach E, Jilo A et al (2012) Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia. Leuk Lymphoma 53:1569-1576
104. Tso PH, Wang YC, Yung LY, Tong Y, Lee MMK, Wong YH (2013) RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras. Cell Signal 25:1064-1074
105. Urano T, Takamiya K, Furukawa K, Shiku H (1992) Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23-M2. FEBS Lett 309:358-362
106. Valentijn LJ, Koppen A, van Asperen R et al (2005) Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 65:3136-3145
107. van Steensel B, de Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743
108. Webb PA, Perisic O, Mendola CE, Backer JM, Williams RL (1995) The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. J Mol Biol 251:574-587
109. Wei SJ, Trempus CS, Ali RC, Hansen LA, Tennant RW (2004) 12-O-tetradecanoylphorbol-13-acetate and UV radiation-induced nucleoside diphosphate protein kinase B mediates neoplastic transformation of epidermal cells. J Biol Chem 279:5993-6004
110. Wieland T (2007) Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability. Naunyn Schmiedebergs Arch Pharmacol 374:373-383
111. Willems R, Van Bockstaele DR, Lardon F et al (1998) Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation. J Biol Chem 273:13663-13668
112. Willems R, Slegers H, Rodrigus I et al (2002) Extracellular nucleoside diphosphate kinase NM23/NDPK modulates normal hematopoietic differentiation. Expt Hematol 30:640-648
113. Wuelling M, Delling G, Kaiser E (2004) Differential gene expression in stromal cells of human giant cell tumor of bone. Virchows Arch 445:621-630
114. Xu JD, Cao XX, Long ZW et al (2011) BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells. J Pathol 223:400-409
115. Yamashiro S, Urano T, Shiku H, Furukawa K (1994) Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. Oncogene 9:2461-2468
116. Yao Y, Li C, Zhou X et al. (2014) PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation. Oncotarget 5:8466-8477
117. Yokoyama A, Okabe-Kado J, Sakashita A et al (1996) Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia. Blood 88:3555-3561
118. Yung LY, Lam WS, Ho MK et al (2012) Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types. Planta Medica 78:115-121
119. Zhu S, Wurdak H, Wang J et al (2009) A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4:416-426